Hilleman Jeryl L

Hilleman Jeryl L is listed in filings as Director at NovoCure Ltd. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to NovoCure Ltd (NVCR), Omada Health (OMDA), HilleVax, Inc. (HLVX), and SI-BONE, Inc. (SIBN). The current snapshot covers public activity from Jun 27, 2024 to Jun 5, 2026. Reported amounts are shown as $274.5K to $115.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.